Selected research
Market Structure
Global Fludeoxyglucose F 18 Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Fludeoxyglucose F 18 Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Fludeoxyglucose F 18 Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fludeoxyglucose F 18 Injection include China Isotope & Radiation Corporation, Hta Co., Ltd, Yantai Dongcheng Biochemicals Co.,Ltd., Shanghai Atom Kexing Pharmaceutical Co.,Ltd., HUAYI Technology, Guangdong Cyclotron Medical Science Co., Ltd, Siemens(PETNet) and Isologic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Fludeoxyglucose F 18 Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Fludeoxyglucose F 18 Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Fludeoxyglucose F 18 Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fludeoxyglucose F 18 Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Fludeoxyglucose F 18 Injection Segment by Company
China Isotope & Radiation Corporation
Hta Co., Ltd
Yantai Dongcheng Biochemicals Co.,Ltd.
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
HUAYI Technology
Guangdong Cyclotron Medical Science Co., Ltd
Siemens(PETNet)
Isologic
Fludeoxyglucose F 18 Injection Segment by Type
<200 mCi/1mL
>300 mCi/1mL
200-300 mCi/1mL
Fludeoxyglucose F 18 Injection Segment by Application
Heart Disease
Epilepsy
Cancer
Fludeoxyglucose F 18 Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fludeoxyglucose F 18 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fludeoxyglucose F 18 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fludeoxyglucose F 18 Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Fludeoxyglucose F 18 Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fludeoxyglucose F 18 Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fludeoxyglucose F 18 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Fludeoxyglucose F 18 Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- <200 mCi/1mL
- >300 mCi/1mL
- 200-300 mCi/1mL
Applications
- Heart Disease
- Epilepsy
- Cancer
Companies covered
- China Isotope & Radiation Corporation
- Hta Co., Ltd
- Yantai Dongcheng Biochemicals Co.,Ltd.
- Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
- HUAYI Technology
- Guangdong Cyclotron Medical Science Co., Ltd
- Siemens(PETNet)
- Isologic
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Fludeoxyglucose F 18 Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Fludeoxyglucose F 18 Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Fludeoxyglucose F 18 Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Fludeoxyglucose F 18 Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Fludeoxyglucose F 18 Injection Market Dynamics
- 2.1 Fludeoxyglucose F 18 Injection Industry Trends
- 2.2 Fludeoxyglucose F 18 Injection Industry Drivers
- 2.3 Fludeoxyglucose F 18 Injection Industry Opportunities and Challenges
- 2.4 Fludeoxyglucose F 18 Injection Industry Restraints
3 Fludeoxyglucose F 18 Injection Market by Manufacturers
- 3.1 Global Fludeoxyglucose F 18 Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Fludeoxyglucose F 18 Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Fludeoxyglucose F 18 Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Fludeoxyglucose F 18 Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fludeoxyglucose F 18 Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Fludeoxyglucose F 18 Injection Manufacturers, Product Type & Application
- 3.7 Global Fludeoxyglucose F 18 Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fludeoxyglucose F 18 Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fludeoxyglucose F 18 Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Fludeoxyglucose F 18 Injection Tier 1, Tier 2, and Tier 3
4 Fludeoxyglucose F 18 Injection Market by Type
- 4.1 Fludeoxyglucose F 18 Injection Type Introduction
- 4.1.1 <200 mCi/1mL
- 4.1.2 >300 mCi/1mL
- 4.1.3 200-300 mCi/1mL
- 4.2 Global Fludeoxyglucose F 18 Injection Sales by Type
- 4.2.1 Global Fludeoxyglucose F 18 Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Fludeoxyglucose F 18 Injection Sales by Type (2021-2032)
- 4.2.3 Global Fludeoxyglucose F 18 Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Fludeoxyglucose F 18 Injection Revenue by Type
- 4.3.1 Global Fludeoxyglucose F 18 Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Fludeoxyglucose F 18 Injection Revenue by Type (2021-2032)
- 4.3.3 Global Fludeoxyglucose F 18 Injection Revenue Market Share by Type (2021-2032)
5 Fludeoxyglucose F 18 Injection Market by Application
- 5.1 Fludeoxyglucose F 18 Injection Application Introduction
- 5.1.1 Heart Disease
- 5.1.2 Epilepsy
- 5.1.3 Cancer
- 5.2 Global Fludeoxyglucose F 18 Injection Sales by Application
- 5.2.1 Global Fludeoxyglucose F 18 Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Fludeoxyglucose F 18 Injection Sales by Application (2021-2032)
- 5.2.3 Global Fludeoxyglucose F 18 Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Fludeoxyglucose F 18 Injection Revenue by Application
- 5.3.1 Global Fludeoxyglucose F 18 Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Fludeoxyglucose F 18 Injection Revenue by Application (2021-2032)
- 5.3.3 Global Fludeoxyglucose F 18 Injection Revenue Market Share by Application (2021-2032)
6 Global Fludeoxyglucose F 18 Injection Sales by Region
- 6.1 Global Fludeoxyglucose F 18 Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Fludeoxyglucose F 18 Injection Sales by Region (2021-2032)
- 6.2.1 Global Fludeoxyglucose F 18 Injection Sales by Region (2021-2026)
- 6.2.2 Global Fludeoxyglucose F 18 Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Fludeoxyglucose F 18 Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Fludeoxyglucose F 18 Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Fludeoxyglucose F 18 Injection Revenue by Region
- 7.1 Global Fludeoxyglucose F 18 Injection Revenue by Region
- 7.1.1 Global Fludeoxyglucose F 18 Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Fludeoxyglucose F 18 Injection Revenue by Region (2021-2026)
- 7.1.3 Global Fludeoxyglucose F 18 Injection Revenue by Region (2027-2032)
- 7.1.4 Global Fludeoxyglucose F 18 Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Fludeoxyglucose F 18 Injection Revenue (2021-2032)
- 7.2.2 North America Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Fludeoxyglucose F 18 Injection Revenue (2021-2032)
- 7.3.2 Europe Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Fludeoxyglucose F 18 Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Fludeoxyglucose F 18 Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Fludeoxyglucose F 18 Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 China Isotope & Radiation Corporation
- 8.1.1 China Isotope & Radiation Corporation Company Information
- 8.1.2 China Isotope & Radiation Corporation Business Overview
- 8.1.3 China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 China Isotope & Radiation Corporation Fludeoxyglucose F 18 Injection Product Portfolio
- 8.1.5 China Isotope & Radiation Corporation Recent Developments
- 8.2 Hta Co., Ltd
- 8.2.1 Hta Co., Ltd Company Information
- 8.2.2 Hta Co., Ltd Business Overview
- 8.2.3 Hta Co., Ltd Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Hta Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio
- 8.2.5 Hta Co., Ltd Recent Developments
- 8.3 Yantai Dongcheng Biochemicals Co.,Ltd.
- 8.3.1 Yantai Dongcheng Biochemicals Co.,Ltd. Company Information
- 8.3.2 Yantai Dongcheng Biochemicals Co.,Ltd. Business Overview
- 8.3.3 Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Yantai Dongcheng Biochemicals Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio
- 8.3.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments
- 8.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
- 8.4.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information
- 8.4.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Business Overview
- 8.4.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Fludeoxyglucose F 18 Injection Product Portfolio
- 8.4.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Recent Developments
- 8.5 HUAYI Technology
- 8.5.1 HUAYI Technology Company Information
- 8.5.2 HUAYI Technology Business Overview
- 8.5.3 HUAYI Technology Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 HUAYI Technology Fludeoxyglucose F 18 Injection Product Portfolio
- 8.5.5 HUAYI Technology Recent Developments
- 8.6 Guangdong Cyclotron Medical Science Co., Ltd
- 8.6.1 Guangdong Cyclotron Medical Science Co., Ltd Company Information
- 8.6.2 Guangdong Cyclotron Medical Science Co., Ltd Business Overview
- 8.6.3 Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Guangdong Cyclotron Medical Science Co., Ltd Fludeoxyglucose F 18 Injection Product Portfolio
- 8.6.5 Guangdong Cyclotron Medical Science Co., Ltd Recent Developments
- 8.7 Siemens(PETNet)
- 8.7.1 Siemens(PETNet) Company Information
- 8.7.2 Siemens(PETNet) Business Overview
- 8.7.3 Siemens(PETNet) Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Siemens(PETNet) Fludeoxyglucose F 18 Injection Product Portfolio
- 8.7.5 Siemens(PETNet) Recent Developments
- 8.8 Isologic
- 8.8.1 Isologic Company Information
- 8.8.2 Isologic Business Overview
- 8.8.3 Isologic Fludeoxyglucose F 18 Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Isologic Fludeoxyglucose F 18 Injection Product Portfolio
- 8.8.5 Isologic Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Fludeoxyglucose F 18 Injection Value Chain Analysis
- 9.1.1 Fludeoxyglucose F 18 Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Fludeoxyglucose F 18 Injection Production Mode & Process
- 9.2 Fludeoxyglucose F 18 Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Fludeoxyglucose F 18 Injection Distributors
- 9.2.3 Fludeoxyglucose F 18 Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst